[1]
Wang Y, Li W, Peng W, Zhou J, Liu Z. Acupuncture for postherpetic neuralgia: Systematic review and meta-analysis. Medicine. 2018 Aug:97(34):e11986. doi: 10.1097/MD.0000000000011986. Epub
[PubMed PMID: 30142834]
Level 1 (high-level) evidence
[2]
Çakici N, Fakkel TM, van Neck JW, Verhagen AP, Coert JH. Systematic review of treatments for diabetic peripheral neuropathy. Diabetic medicine : a journal of the British Diabetic Association. 2016 Nov:33(11):1466-1476. doi: 10.1111/dme.13083. Epub 2016 Feb 21
[PubMed PMID: 26822889]
Level 1 (high-level) evidence
[3]
Dewanjee S, Das S, Das AK, Bhattacharjee N, Dihingia A, Dua TK, Kalita J, Manna P. Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets. European journal of pharmacology. 2018 Aug 15:833():472-523. doi: 10.1016/j.ejphar.2018.06.034. Epub 2018 Jun 30
[PubMed PMID: 29966615]
[4]
Alavi A, Sibbald RG, Mayer D, Goodman L, Botros M, Armstrong DG, Woo K, Boeni T, Ayello EA, Kirsner RS. Diabetic foot ulcers: Part I. Pathophysiology and prevention. Journal of the American Academy of Dermatology. 2014 Jan:70(1):1.e1-18; quiz 19-20. doi: 10.1016/j.jaad.2013.06.055. Epub
[PubMed PMID: 24355275]
[5]
Vinik AI, Casellini C, Névoret ML. Alternative Quantitative Tools in the Assessment of Diabetic Peripheral and Autonomic Neuropathy. International review of neurobiology. 2016:127():235-85. doi: 10.1016/bs.irn.2016.03.010. Epub 2016 Apr 13
[PubMed PMID: 27133153]
Level 3 (low-level) evidence
[6]
Elafros MA, Andersen H, Bennett DL, Savelieff MG, Viswanathan V, Callaghan BC, Feldman EL. Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments. The Lancet. Neurology. 2022 Oct:21(10):922-936. doi: 10.1016/S1474-4422(22)00188-0. Epub
[PubMed PMID: 36115364]
[7]
Baum P, Toyka KV, Blüher M, Kosacka J, Nowicki M. Inflammatory Mechanisms in the Pathophysiology of Diabetic Peripheral Neuropathy (DN)-New Aspects. International journal of molecular sciences. 2021 Oct 7:22(19):. doi: 10.3390/ijms221910835. Epub 2021 Oct 7
[PubMed PMID: 34639176]
[8]
Vinik AI, Casellini C, Parson HK, Colberg SR, Nevoret ML. Cardiac Autonomic Neuropathy in Diabetes: A Predictor of Cardiometabolic Events. Frontiers in neuroscience. 2018:12():591. doi: 10.3389/fnins.2018.00591. Epub 2018 Aug 27
[PubMed PMID: 30210276]
Level 3 (low-level) evidence
[9]
Sloan G, Shillo P, Selvarajah D, Wu J, Wilkinson ID, Tracey I, Anand P, Tesfaye S. A new look at painful diabetic neuropathy. Diabetes research and clinical practice. 2018 Oct:144():177-191. doi: 10.1016/j.diabres.2018.08.020. Epub 2018 Sep 7
[PubMed PMID: 30201394]
[10]
Julian T, Glascow N, Syeed R, Zis P. Alcohol-related peripheral neuropathy: a systematic review and meta-analysis. Journal of neurology. 2019 Dec:266(12):2907-2919. doi: 10.1007/s00415-018-9123-1. Epub 2018 Nov 22
[PubMed PMID: 30467601]
Level 1 (high-level) evidence
[11]
Gwathmey KG, Grogan J. Nutritional neuropathies. Muscle & nerve. 2020 Jul:62(1):13-29. doi: 10.1002/mus.26783. Epub 2019 Dec 26
[PubMed PMID: 31837157]
[12]
Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barré syndrome. Lancet (London, England). 2016 Aug 13:388(10045):717-27. doi: 10.1016/S0140-6736(16)00339-1. Epub 2016 Mar 2
[PubMed PMID: 26948435]
[13]
Freund PR, Wright T, Margolin EA. Toxic Optic Neuropathy From Quinine Overdose. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2020 Jun:40(2):258-261. doi: 10.1097/WNO.0000000000000865. Epub
[PubMed PMID: 31842144]
[14]
Guala A, Folgori G, Silvestri M, Barbaglia M, Danesino C. Vitamin B6 Neonatal Toxicity. Case reports in pediatrics. 2022:2022():3171351. doi: 10.1155/2022/3171351. Epub 2022 Dec 6
[PubMed PMID: 36524152]
Level 3 (low-level) evidence
[15]
Malet L, Dayot L, Moussy M, de la Gastine B, Goutelle S. [Peripheral neuropathy with hypervitaminosis B6 caused by self-medication]. La Revue de medecine interne. 2020 Feb:41(2):126-129. doi: 10.1016/j.revmed.2019.11.003. Epub 2019 Nov 30
[PubMed PMID: 31796339]
[16]
Ko JU, Seo H, Lee GJ, Park D. Bilateral sciatic neuropathy with severe rhabdomyolysis following venlafaxine overdose: A case report. Medicine. 2018 Sep:97(37):e12220. doi: 10.1097/MD.0000000000012220. Epub
[PubMed PMID: 30212953]
Level 3 (low-level) evidence
[17]
Ly KI, Blakeley JO. The Diagnosis and Management of Neurofibromatosis Type 1. The Medical clinics of North America. 2019 Nov:103(6):1035-1054. doi: 10.1016/j.mcna.2019.07.004. Epub
[PubMed PMID: 31582003]
[18]
Jani-Acsadi A, Ounpuu S, Pierz K, Acsadi G. Pediatric Charcot-Marie-Tooth disease. Pediatric clinics of North America. 2015 Jun:62(3):767-86. doi: 10.1016/j.pcl.2015.03.012. Epub 2015 Apr 15
[PubMed PMID: 26022174]
[19]
Freeman R. Autonomic Peripheral Neuropathy. Continuum (Minneapolis, Minn.). 2020 Feb:26(1):58-71. doi: 10.1212/CON.0000000000000825. Epub
[PubMed PMID: 31996622]
[20]
Kaku M, Berk JL. Neuropathy Associated with Systemic Amyloidosis. Seminars in neurology. 2019 Oct:39(5):578-588. doi: 10.1055/s-0039-1688994. Epub 2019 Oct 22
[PubMed PMID: 31639841]
[21]
Gandhi Mehta RK, Caress JB, Rudnick SR, Bonkovsky HL. Porphyric neuropathy. Muscle & nerve. 2021 Aug:64(2):140-152. doi: 10.1002/mus.27232. Epub 2021 Mar 31
[PubMed PMID: 33786855]
[22]
Gerischer LM, Scheibe F, Nümann A, Köhnlein M, Stölzel U, Meisel A. Acute porphyrias - A neurological perspective. Brain and behavior. 2021 Nov:11(11):e2389. doi: 10.1002/brb3.2389. Epub 2021 Oct 17
[PubMed PMID: 34661997]
Level 3 (low-level) evidence
[23]
Abrams RMC, Simpson DM, Navis A, Jette N, Zhou L, Shin SC. Small fiber neuropathy associated with SARS-CoV-2 infection. Muscle & nerve. 2022 Apr:65(4):440-443. doi: 10.1002/mus.27458. Epub 2021 Nov 22
[PubMed PMID: 34766365]
[24]
Saif DS, Ibrahem RA, Eltabl MA. Prevalence of peripheral neuropathy and myopathy in patients post-COVID-19 infection. International journal of rheumatic diseases. 2022 Nov:25(11):1246-1253. doi: 10.1111/1756-185X.14409. Epub 2022 Aug 1
[PubMed PMID: 35915515]
[25]
Benstead TJ, Chalk CH, Parks NE. Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection. The Cochrane database of systematic reviews. 2014 Dec 20:(12):CD010404. doi: 10.1002/14651858.CD010404.pub2. Epub 2014 Dec 20
[PubMed PMID: 25525951]
Level 1 (high-level) evidence
[26]
Ferro JM, Oliveira Santos M. Neurology of inflammatory bowel disease. Journal of the neurological sciences. 2021 May 15:424():117426. doi: 10.1016/j.jns.2021.117426. Epub 2021 Mar 27
[PubMed PMID: 33810878]
[27]
García-Cabo C, Morís G. Peripheral neuropathy: an underreported neurologic manifestation of inflammatory bowel disease. European journal of internal medicine. 2015 Sep:26(7):468-75. doi: 10.1016/j.ejim.2015.07.013. Epub 2015 Jul 23
[PubMed PMID: 26211733]
[28]
Seeliger T, Prenzler NK, Gingele S, Seeliger B, Körner S, Thiele T, Bönig L, Sühs KW, Witte T, Stangel M, Skripuletz T. Neuro-Sjögren: Peripheral Neuropathy With Limb Weakness in Sjögren's Syndrome. Frontiers in immunology. 2019:10():1600. doi: 10.3389/fimmu.2019.01600. Epub 2019 Jul 11
[PubMed PMID: 31354737]
[29]
Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, Colvin LA, Fallon M. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain. 2014 Dec:155(12):2461-2470. doi: 10.1016/j.pain.2014.09.020. Epub 2014 Sep 23
[PubMed PMID: 25261162]
Level 1 (high-level) evidence
[30]
Sałat K. Chemotherapy-induced peripheral neuropathy-part 2: focus on the prevention of oxaliplatin-induced neurotoxicity. Pharmacological reports : PR. 2020 Jun:72(3):508-527. doi: 10.1007/s43440-020-00106-1. Epub 2020 Apr 28
[PubMed PMID: 32347537]
[31]
Staff NP, Grisold A, Grisold W, Windebank AJ. Chemotherapy-induced peripheral neuropathy: A current review. Annals of neurology. 2017 Jun:81(6):772-781. doi: 10.1002/ana.24951. Epub 2017 Jun 5
[PubMed PMID: 28486769]
[32]
Zajączkowska R, Kocot-Kępska M, Leppert W, Wrzosek A, Mika J, Wordliczek J. Mechanisms of Chemotherapy-Induced Peripheral Neuropathy. International journal of molecular sciences. 2019 Mar 22:20(6):. doi: 10.3390/ijms20061451. Epub 2019 Mar 22
[PubMed PMID: 30909387]
[33]
Taylor CA, Braza D, Rice JB, Dillingham T. The incidence of peripheral nerve injury in extremity trauma. American journal of physical medicine & rehabilitation. 2008 May:87(5):381-5. doi: 10.1097/PHM.0b013e31815e6370. Epub
[PubMed PMID: 18334923]
[34]
Noland SS, Bishop AT, Spinner RJ, Shin AY. Adult Traumatic Brachial Plexus Injuries. The Journal of the American Academy of Orthopaedic Surgeons. 2019 Oct 1:27(19):705-716. doi: 10.5435/JAAOS-D-18-00433. Epub
[PubMed PMID: 30707114]
[35]
Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, Wilson DM, O'Brien PC, Melton LJ 3rd, Service FJ. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993 Apr:43(4):817-24
[PubMed PMID: 8469345]
[36]
Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, Sosenko JM, Ziegler D. Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes care. 2017 Jan:40(1):136-154. doi: 10.2337/dc16-2042. Epub
[PubMed PMID: 27999003]
[37]
Hjelm LR. Diabetes Mellitus: An Overview in Relationship to Charcot Neuroarthropathy. Clinics in podiatric medicine and surgery. 2022 Oct:39(4):535-542. doi: 10.1016/j.cpm.2022.05.001. Epub 2022 Aug 6
[PubMed PMID: 36180186]
Level 3 (low-level) evidence
[38]
Djibril AM, Mossi EK, Djagadou AK, Balaka A, Tchamdja T, Moukaila R. [Epidemiological, diagnostic, therapeutic and evolutionary features of diabetic foot: a study conducted at the Medico-surgical Clinic, University Hospital Sylvanus Olympio in Lomé]. The Pan African medical journal. 2018:30():4. doi: 10.11604/pamj.2018.30.4.14765. Epub 2018 May 3
[PubMed PMID: 30123407]
Level 2 (mid-level) evidence
[39]
Ghotaslou R, Memar MY, Alizadeh N. Classification, microbiology and treatment of diabetic foot infections. Journal of wound care. 2018 Jul 2:27(7):434-441. doi: 10.12968/jowc.2018.27.7.434. Epub
[PubMed PMID: 30016139]
[40]
Schröder K, Szendroedi J, Benthin A, Gontscharuk V, Ackermann P, Völker M, Steingrube N, Nowotny B, Ziegler D, Müssig K, Geerling G, Kuß O, Roden M, Guthoff R, GDS Cohort. German Diabetes Study - Baseline data of retinal layer thickness measured by SD-OCT in early diabetes mellitus. Acta ophthalmologica. 2019 Mar:97(2):e303-e307. doi: 10.1111/aos.13851. Epub 2018 Sep 21
[PubMed PMID: 30238609]
[41]
Moţăţăianu A, Maier S, Bajko Z, Voidazan S, Bălaşa R, Stoian A. Cardiac autonomic neuropathy in type 1 and type 2 diabetes patients. BMC neurology. 2018 Aug 27:18(1):126. doi: 10.1186/s12883-018-1125-1. Epub 2018 Aug 27
[PubMed PMID: 30149797]
[42]
Doria M, Viadé J, Palomera E, Pérez R, Lladó M, Costa E, Huguet T, Reverter JL, Serra-Prat M, Franch-Nadal J, Mauricio D. Short-term foot complications in Charcot neuroarthropathy: A retrospective study in tertiary care centres in Spain. Endocrinologia, diabetes y nutricion. 2018 Nov:65(9):479-485. doi: 10.1016/j.endinu.2018.06.004. Epub 2018 Aug 11
[PubMed PMID: 30108031]
Level 2 (mid-level) evidence
[43]
Giri B, Dey S, Das T, Sarkar M, Banerjee J, Dash SK. Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: An update on glucose toxicity. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2018 Nov:107():306-328. doi: 10.1016/j.biopha.2018.07.157. Epub 2018 Aug 8
[PubMed PMID: 30098549]
[44]
Sloan G, Selvarajah D, Tesfaye S. Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy. Nature reviews. Endocrinology. 2021 Jul:17(7):400-420. doi: 10.1038/s41574-021-00496-z. Epub 2021 May 28
[PubMed PMID: 34050323]
[45]
Sène D. Small fiber neuropathy: Diagnosis, causes, and treatment. Joint bone spine. 2018 Oct:85(5):553-559. doi: 10.1016/j.jbspin.2017.11.002. Epub 2017 Nov 16
[PubMed PMID: 29154979]
[46]
Chedid V, Brandler J, Vijayvargiya P, Park SY, Szarka LA, Camilleri M. Characterization of Upper Gastrointestinal Symptoms, Gastric Motor Functions, and Associations in Patients with Diabetes at a Referral Center. The American journal of gastroenterology. 2019 Jan:114(1):143-154. doi: 10.1038/s41395-018-0234-1. Epub
[PubMed PMID: 30166634]
[47]
Petropoulos IN, Ponirakis G, Khan A, Almuhannadi H, Gad H, Malik RA. Diagnosing Diabetic Neuropathy: Something Old, Something New. Diabetes & metabolism journal. 2018 Aug:42(4):255-269. doi: 10.4093/dmj.2018.0056. Epub
[PubMed PMID: 30136449]
[48]
D'Souza RS, Barman R, Joseph A, Abd-Elsayed A. Evidence-Based Treatment of Painful Diabetic Neuropathy: a Systematic Review. Current pain and headache reports. 2022 Aug:26(8):583-594. doi: 10.1007/s11916-022-01061-7. Epub 2022 Jun 18
[PubMed PMID: 35716275]
Level 1 (high-level) evidence
[49]
Shakhatreh M, Jehangir A, Malik Z, Parkman HP. Metoclopramide for the treatment of diabetic gastroparesis. Expert review of gastroenterology & hepatology. 2019 Aug:13(8):711-721. doi: 10.1080/17474124.2019.1645594. Epub 2019 Jul 30
[PubMed PMID: 31314613]
[50]
Frazee LA, Mauro LS. Erythromycin in the Treatment of Diabetic Gastroparesis. American journal of therapeutics. 1994 Dec:1(4):287-295
[PubMed PMID: 11835102]
[51]
Stevens JE, Jones KL, Rayner CK, Horowitz M. Pathophysiology and pharmacotherapy of gastroparesis: current and future perspectives. Expert opinion on pharmacotherapy. 2013 Jun:14(9):1171-86. doi: 10.1517/14656566.2013.795948. Epub 2013 May 11
[PubMed PMID: 23663133]
Level 3 (low-level) evidence
[52]
Mobley DF, Khera M, Baum N. Recent advances in the treatment of erectile dysfunction. Postgraduate medical journal. 2017 Nov:93(1105):679-685. doi: 10.1136/postgradmedj-2016-134073. Epub 2017 Jul 27
[PubMed PMID: 28751439]
Level 3 (low-level) evidence
[53]
Palma JA, Kaufmann H. Management of Orthostatic Hypotension. Continuum (Minneapolis, Minn.). 2020 Feb:26(1):154-177. doi: 10.1212/CON.0000000000000816. Epub
[PubMed PMID: 31996627]
[54]
Zhang AC, De Silva MEH, MacIsaac RJ, Roberts L, Kamel J, Craig JP, Busija L, Downie LE. Omega-3 polyunsaturated fatty acid oral supplements for improving peripheral nerve health: a systematic review and meta-analysis. Nutrition reviews. 2020 Apr 1:78(4):323-341. doi: 10.1093/nutrit/nuz054. Epub
[PubMed PMID: 31532492]
Level 1 (high-level) evidence
[55]
Chinnery HR, Naranjo Golborne C, Downie LE. Omega-3 supplementation is neuroprotective to corneal nerves in dry eye disease: a pilot study. Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists). 2017 Jul:37(4):473-481. doi: 10.1111/opo.12365. Epub 2017 Mar 12
[PubMed PMID: 28295445]
Level 3 (low-level) evidence
[56]
Putz Z, Tordai D, Hajdú N, Vági OE, Kempler M, Békeffy M, Körei AE, Istenes I, Horváth V, Stoian AP, Rizzo M, Papanas N, Kempler P. Vitamin D in the Prevention and Treatment of Diabetic Neuropathy. Clinical therapeutics. 2022 May:44(5):813-823. doi: 10.1016/j.clinthera.2022.03.012. Epub 2022 Apr 12
[PubMed PMID: 35428527]
[57]
Alam U, Fawwad A, Shaheen F, Tahir B, Basit A, Malik RA. Improvement in Neuropathy Specific Quality of Life in Patients with Diabetes after Vitamin D Supplementation. Journal of diabetes research. 2017:2017():7928083. doi: 10.1155/2017/7928083. Epub 2017 Dec 28
[PubMed PMID: 29445752]
Level 2 (mid-level) evidence
[58]
Esposito C, Ugo Garzarella E, Santarcangelo C, Di Minno A, Dacrema M, Sacchi R, Piccinocchi G, Piccinocchi R, Daglia M. Safety and efficacy of alpha-lipoic acid oral supplementation in the reduction of pain with unknown etiology: A monocentric, randomized, double-blind, placebo-controlled clinical trial. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2021 Dec:144():112308. doi: 10.1016/j.biopha.2021.112308. Epub 2021 Oct 12
[PubMed PMID: 34649217]
Level 1 (high-level) evidence
[59]
Jeffrey S, Samraj PI, Raj BS. The Role of Alpha-lipoic Acid Supplementation in the Prevention of Diabetes Complications: A Comprehensive Review of Clinical Trials. Current diabetes reviews. 2021:17(9):e011821190404. doi: 10.2174/1573399817666210118145550. Epub
[PubMed PMID: 33461470]
[60]
. Retraction. Alpha-lipoic acid supplementation and diabetes. Nutrition reviews. 2012 Aug:70(8):482. doi: 10.1111/j.1753-4887.2012.00507.x. Epub 2012 Jun 15
[PubMed PMID: 22835141]
[61]
Fonseca VA, Lavery LA, Thethi TK, Daoud Y, DeSouza C, Ovalle F, Denham DS, Bottiglieri T, Sheehan P, Rosenstock J. Metanx in type 2 diabetes with peripheral neuropathy: a randomized trial. The American journal of medicine. 2013 Feb:126(2):141-9. doi: 10.1016/j.amjmed.2012.06.022. Epub 2012 Dec 5
[PubMed PMID: 23218892]
Level 1 (high-level) evidence
[62]
Jayabalan B, Low LL. Vitamin B supplementation for diabetic peripheral neuropathy. Singapore medical journal. 2016 Feb:57(2):55-9. doi: 10.11622/smedj.2016027. Epub
[PubMed PMID: 26892473]
[63]
Krishnasamy S, Abell TL. Diabetic Gastroparesis: Principles and Current Trends in Management. Diabetes therapy : research, treatment and education of diabetes and related disorders. 2018 Jul:9(Suppl 1):1-42. doi: 10.1007/s13300-018-0454-9. Epub 2018 Jun 22
[PubMed PMID: 29934758]
[64]
Garcia-Klepzig JL, Sánchez-Ríos JP, Manu C, Ahluwalia R, Lüdemann C, Meloni M, Lacopi E, De Buruaga VR, Bouillet B, Vouillarmet J, Lázaro-Martínez JL, Van Acker K. Perception of diabetic foot ulcers among general practitioners in four European countries: knowledge, skills and urgency. Journal of wound care. 2018 May 2:27(5):310-319. doi: 10.12968/jowc.2018.27.5.310. Epub
[PubMed PMID: 29738299]
[65]
Iqbal Z, Azmi S, Yadav R, Ferdousi M, Kumar M, Cuthbertson DJ, Lim J, Malik RA, Alam U. Diabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and Pharmacotherapy. Clinical therapeutics. 2018 Jun:40(6):828-849. doi: 10.1016/j.clinthera.2018.04.001. Epub 2018 Apr 30
[PubMed PMID: 29709457]
[66]
Simpson DM, Robinson-Papp J, Van J, Stoker M, Jacobs H, Snijder RJ, Schregardus DS, Long SK, Lambourg B, Katz N. Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study. The journal of pain. 2017 Jan:18(1):42-53. doi: 10.1016/j.jpain.2016.09.008. Epub 2016 Oct 13
[PubMed PMID: 27746370]
Level 1 (high-level) evidence
[67]
Vinik AI, Perrot S, Vinik EJ, Pazdera L, Jacobs H, Stoker M, Long SK, Snijder RJ, van der Stoep M, Ortega E, Katz N. Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study. BMC neurology. 2016 Dec 6:16(1):251
[PubMed PMID: 27919222]
Level 1 (high-level) evidence
[68]
Boulton AJ. Diabetic neuropathy: classification, measurement and treatment. Current opinion in endocrinology, diabetes, and obesity. 2007 Apr:14(2):141-5
[PubMed PMID: 17940432]
Level 3 (low-level) evidence
[69]
Thomas PK. Classification, differential diagnosis, and staging of diabetic peripheral neuropathy. Diabetes. 1997 Sep:46 Suppl 2():S54-7
[PubMed PMID: 9285500]
[70]
Zafeiri M, Tsioutis C, Kleinaki Z, Manolopoulos P, Ioannidis I, Dimitriadis G. Clinical Characteristics of Patients with co-Existent Diabetic Peripheral Neuropathy and Depression: A Systematic Review. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association. 2021 Feb:129(2):77-85. doi: 10.1055/a-0741-6937. Epub 2018 Sep 26
[PubMed PMID: 30257266]
Level 1 (high-level) evidence
[71]
Dyck PJ. Detection, characterization, and staging of polyneuropathy: assessed in diabetics. Muscle & nerve. 1988 Jan:11(1):21-32
[PubMed PMID: 3277049]
[72]
Ferraresi R, Casini A, Caminiti M, Losurdo F, Clerici G. [Multidisciplinary approach to diabetic foot: a challenge of expertises]. Giornale italiano di cardiologia (2006). 2018 Sep:19(9):495-503. doi: 10.1714/2951.29668. Epub
[PubMed PMID: 30087510]
[73]
Jiménez S, Rubio JA, Álvarez J, Lázaro-Martínez JL. Analysis of recurrent ulcerations at a multidisciplinary diabetic Foot unit after implementation of a comprehensive Foot care program. Endocrinologia, diabetes y nutricion. 2018 Oct:65(8):438.e1-438.e10. doi: 10.1016/j.endinu.2018.03.012. Epub 2018 Jun 15
[PubMed PMID: 29914816]
[74]
Edwards RA, Bonfanti G, Grugni R, Manca L, Parsons B, Alexander J. Predicting Responses to Pregabalin for Painful Diabetic Peripheral Neuropathy Based on Trajectory-Focused Patient Profiles Derived from the First 4 Weeks of Treatment. Advances in therapy. 2018 Oct:35(10):1585-1597. doi: 10.1007/s12325-018-0780-3. Epub 2018 Sep 11
[PubMed PMID: 30206821]
Level 3 (low-level) evidence